Cargando…
Presenting features and long-term effects of growth hormone treatment of children with optic nerve hypoplasia/septo-optic dysplasia
BACKGROUND: Optic nerve hypoplasia (ONH) with/or without septo-optic dysplasia (SOD) is a known concomitant of congenital growth hormone deficiency (CGHD). METHODS: Demographic and longitudinal data from KIGS, the Pfizer International Growth Database, were compared between 395 subjects with ONH/SOD...
Autores principales: | Vedin, Amy M, Karlsson, Hanna, Fink, Cassandra, Borchert, Mark, Geffner, Mitchell E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256097/ https://www.ncbi.nlm.nih.gov/pubmed/22085631 http://dx.doi.org/10.1186/1687-9856-2011-17 |
Ejemplares similares
-
Septo-optic dysplasia with olfactory tract hypoplasia
por: Ribeiro, Manuel, et al.
Publicado: (2009) -
Efficacy of growth hormone replacement on anthropometric outcomes, obesity, and lipids in children with optic nerve hypoplasia and growth hormone deficiency
por: Stewart, Carly, et al.
Publicado: (2016) -
Neuroimaging of septo-optic dysplasia-plus with midbrain hypoplasia and ophthalmoplegia
por: Wang, Colin Y., et al.
Publicado: (2020) -
Septo-optic dysplasia in an infant
por: Aliu, Ermira, et al.
Publicado: (2022) -
Bilateral anophthalmia with septo-optic dysplasia
por: Jana, Manisha, et al.
Publicado: (2010)